 Life Science Investor Mandates
(May 17 - May 23
)
|
|
|
|
|
Invests in Novel Pharmaceutical, Medical Device, and Digital Health Technologies
|
|
Seeks to Invest Up to $5M in Early-Stage Therapeutics Companies with Preference for Platform Technologies
|
|
Seeks Global Opportunities of All Stages that Address Chronic Medical Conditions
|
|
Seeks Digital Health Platform Companies Relating to Drug Discovery, Delivery, and Manufacturing
|
|
LSN's Sourcing & Ranking Service (SRS) provides clients with an opportunity to quickly source, vet, rank and engage with partners that are licensing global technology assets.
|
|
Click to see investors that are a fit for your product and stage of development
|
|
Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you
|
|
Click here if you want to receive free, targeted early stage dealflow for your life science investment firm
|
|
 |
|
By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series
 Life Science Nation(LSN) is launching a new early stage global investor conference called First Coast Healthtech Week, September 5-7th in Boston, MA. The goal is to improve access to the earliest stage companies within the healthcare industry across the First Coast: DC, MD, PA, NJ, NY, RI, CT, and MA essentially the North East Corridor. Life Science Nation wants to expand access to early stage global investors and partners to the earliest stage technology and innovation hubs.
|
 |
 We are excited to showcase the top RESI Innovation Challenge startup applicants, who will be taking part in the poster presentation showcase at the second annual RESI BIO held in Boston this year, alongside the BIO International conference. These handpicked companies represent the key sectors of the healthcare space including therapeutics, medical devices, diagnostics and digital health, and were selected based on their scientific/technical merit and commercial viability. Additionally, this Innovation Challenge will feature select companies from Korea and Taiwan to showcase innovation that is also occurring overseas.
The Innovation Challenge companies will compete for each attendee's RESI Cash tokens throughout the day, which serves as a vote of their potential. The top 3 companies will win additional RESI tickets to events of their choosing and a feature in the LSN newsletter (20,000 readership), giving them access to hundreds of additional investors and ultimately enhancing their likelihood of securing an investment. Make sure to visit the exhibition hall to meet the RESI innovators and "invest" in your favorites!
|
Large corporations, especially in the pharmaceutical/biotech world, play a very important role in anchoring an innovation ecosystem. The most notable activity of these corporations is perhaps their role as an investor in and buyer of innovation, an exit partner; however, attracting and concentrating talent, providing access to resources and experts are also vital elements of a healthy entrepreneurial community that big pharma brings with its presence. Corporate venture funds, which can serve as a vehicle for big pharma to make riskier/earlier investments, continue to find their way into more and more biotech venture rounds every year.
This increasingly important investor class will discuss trends in the space, their current interests and how entrepreneurs can best prepare to pitch to and work with a group like theirs.
Moderated by
Reza Halse, President,
MRL Ventures, this panel will feature:
|
 |
|
Created & Produced by
|
 |
|
|
|
